Since this medicine is administered by a qualified healthcare professional in the clinical or hospital setting, the likelihood of a missed dose is very low. If you miss an appointment for a scheduled dose of this medicine, contact your doctor immediately for further instructions.
Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Leflunomide (severe)
Live attenuated vaccines and related products (severe)
Phenytoin (moderate)
Azathioprine (moderate)
This medicine is used for the treatment of squamous cell carcinoma (abnormal growth of squamous cells) affecting head and neck (including the mouth, nose, throat, etc.) and the skin, cervix or external genitalia.
This medicine is used for the treatment of malignant pleural effusions, a cancerous condition of an abnormal fluid build up in the chest cavity (lungs).
This medicine is used in the treatment of Hodgkin's Disease, cancer that originates in the cells of the immune system.
This medicine is used for the treatment of Non-Hodgkin's lymphoma, a type of cancer that affects certain cells (lymphocytes) of the lymphatic system.
This medicine is used for the treatment of cancer that affects the testicles (male genital organ).
Wheezing
Nausea or Vomiting
Dizziness and lightheadedness
Fever or chills
Loss of appetite
Weight loss
Pain at the injection site
Discoloration of the nails (rare)
Hair loss or thinning of the hair
Cough
Itching and skin rash
Shortness of breath
Mouth sores
This medicine is not recommended for use if you have a known allergy to Bemocin Injection 15 mg 1 Vialx5 mL or any other inactive ingredients present along with it.
Coadministration of Bleocin Injection along with this medicine is not recommended due to the increased risk of serious respiratory complications.
This medicine is not recommended for use in patients with pulmonary infection or lung function impairment due to the increased risk of worsening of the patient's condition.